Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 50
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition

  • Quijada Álamo, Miguel
  • Hernández Sánchez, María
  • Alonso Pérez, Verónica
  • Rodríguez Vicente, Ana E.
  • García Tuñón, Ignacio
  • Martín Izquierdo, Marta
  • Hernández Sánchez, Jesús María
  • Herrero, Ana B.
  • Bastida, José María
  • San Segundo, Laura
  • Gruber, Michaela
  • García, Juan Luis
  • Yin, Shanye
  • Hacken, Elisa ten
  • Benito, Rocío
  • Ordóñez, José Luis
  • Wu, Catherine J.
  • Hernández-Rivas, Jesús María
The deletion of 11q (del(11q)) invariably comprises ATM gene in chronic lymphocytic leukemia (CLL). Concomitant mutations in this gene in the remaining allele have been identified in 1/3 of CLL cases harboring del(11q), being the biallelic loss of ATM associated with adverse prognosis. Although the introduction of targeted BCR inhibition has significantly favored the outcomes of del(11q) patients, responses of patients harboring ATM functional loss through biallelic inactivation are unexplored, and the development of resistances to targeted therapies have been increasingly reported, urging the need to explore novel therapeutic approaches. Here, we generated isogenic CLL cell lines harboring del(11q) and ATM mutations through CRISPR/Cas9-based gene-editing. With these models, we uncovered a novel therapeutic vulnerability of del(11q)/ ATM-mutated cells to dual BCR and PARP inhibition. Ex vivo studies in the presence of stromal stimulation on 38 CLL primary samples confirmed a synergistic action of the combination of olaparib and ibrutinib in del(11q)/ATM-mutated CLL patients. In addition, we showed that ibrutinib produced a homologous recombination repair impairment through RAD51 dysregulation, finding a synergistic link of both drugs in the DNA damage repair pathway. Our data provide a preclinical rationale for the use of this combination in CLL patients with this high-risk cytogenetic abnormality
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Autosomal dominant polycystic kidney disease, possibly the least silent cause of chronic kidney disease

  • Torra Balcells, Roser|||0000-0001-8714-2332
  • Pérez-Gómez, Maria Vanessa|||0000-0003-4558-5236
  • Furlano, Monica|||0000-0003-1025-3901
Pain is the highest prioritized patient-reported outcome in people with autosomal dominant polycystic kidney disease (ADPKD) but it remains infrequently and inconsistently measured across countries, studies and trials. The study by El-Damanawi et al. integrated a network of ADPKD expert clinicians, pain specialists, researchers and patient representatives from the national UK PKD charity, with the aim of addressing the lack of validated ADPKD-specific pain assessment tools (APATs). The APAT designed by the authors included several pain measurement tools and was tested in ADPKD patients, although further validation through assessment in larger cohorts is needed. Establishing a standardized instrument for pain measurement will ensure that pain is measured and reported in a consistent way to inform decision-making and identify effective interventions aimed at managing pain and minimizing the impact pain has on patients with ADPKD. In this context, the APAT established by the authors is to be warmly welcomed.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

New remains of Titanochelon richardi (Testudines, Testudinidae) from the Upper Miocene of the Vallès-Penedès Basin: taxonomic and phylogenetic implications

  • Vega-Pagán, Kelly Ann|||0000-0001-8966-5348
  • Bolet, Arnau|||0000-0003-4416-4560
  • Villa, Andrea|||0000-0001-6544-5201
  • Delfino, Massimo|||0000-0001-7836-7265
  • Fortuny, Josep|||0000-0003-4282-1619
  • Alba, David M.|||0000-0002-8886-5580
  • Luján, Àngel H.|||0000-0003-1844-0453
The alpha-taxonomy of continental giant tortoises (Testudinidae, Titanochelon) from the European Neogene is far from settled, which has implications for inferring their phylogenetic relationships. The diagnosis of the type species (Titanochelon bolivari) is dubious because it considered Titanochelon richardi as a junior subjective synonym. Here we describe a new partial skeleton (skull, partial carapace, plastron, and multiple postcranial elements) from the Late Miocene (9.4-9.1 Ma, MN10) of the Ronda Oest de Sabadell locality ROS-D6 (Vallès-Penedès Basin, NE Iberian Peninsula) that is assigned to T. richardi based on cranial and shell morphology. This skeleton enables a more complete assessment of the skull and postcranium of this species. On this basis, we discount the purported synonymy of T. richardi with T. bolivari and provide an emended diagnosis for the former. We also assess the phylogenetic relationships of Titanochelon species by means of standard maximum parsimony, implied weighting maximum parsimony and Bayesian analyses with morphological and with combined (morphological and molecular) data. Our comparisons support T. richardi as a distinct species unambiguously recorded from the Vallès-Penedès and the Duero basins, from MN7+8 to MN10 (Middle-Late Miocene), whereas T. bolivari appears restricted to MN5-MN6 of the Madrid Basin. Additional Iberian material ranging from MN2 to MN10 should be revised to further clarify the geographic distribution and temporal range of these species. Finally, our analyses provide a better resolved phylogeny for Titanochelon species other than Titanochelon vitodurana and support a sister-taxon relationship between T. bolivari and T. richardi.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Species-specific modulation of food-search behavior by respiration and chemosensation in Drosophila larvae

  • Kim, Daeyeon
  • Alvarez, Mar
  • Lechuga, Laura M.
  • Louis, Matthieu
Animals explore their environment to encounter suitable food resources. Despite its vital importance, this behavior puts individuals at risk by consuming limited internal energy during locomotion. We have developed a novel assay to investigate how food-search behavior is organized in Drosophila melanogaster larvae dwelling in hydrogels mimicking their natural habitat. We define three main behavioral modes: resting at the gel's surface, digging while feeding near the surface, and apneic dives. In unstimulated conditions, larvae spend most of their time digging. By contrast, deep and long exploratory dives are promoted by olfactory stimulations. Hypoxia and chemical repellents impair diving. We report remarkable differences in the dig-and-dive behavior of D. melanogaster and the fruit-pest D. suzukii. The present paradigm offers an opportunity to study how sensory and physiological cues are integrated to balance the limitations of dwelling in imperfect environmental conditions and the risks associated with searching for potentially more favorable conditions., We acknowledge support of the Spanish Ministry of Economy and Competitiveness, 'Centro de Excelencia Severo Ochoa 2013-2017', as well as the support of the CERCA Programme/Generalitat de Catalunya. This work was supported by funding from the Spanish Ministry of Science and Innovation (MICINN, BFU2008-00362 and BFU2011-26208), the EMBL/CRG Systems Biology Program and the EU FET-Open grant MINIMAL.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Sensation of electric fields in the Drosophila melanogaster larva

  • Tadres, David
  • Riedl, Julia, 1981-
  • Eden, Alexander
  • Bontempo, Angela E.
  • Lin, Jingtong
  • Reid, Samuel F.
  • Roehrich, Brian
  • Williams, Kevin
  • Sepunaru, Lior
  • Louis, Matthieu
Electrosensation has emerged as a crucial sensory modality for social communication, foraging, and predation across the animal kingdom. However, its presence and functional role as well as the neural basis of electric field perception in Drosophila and other invertebrates remain unclear. In environments with controlled electric fields, we identified electrosensation as a new sense in the Drosophila melanogaster larva. We found that the Drosophila larva performs robust electrotaxis: when exposed to a uniform electric field, larvae migrate toward the cathode (negatively charged elecrode) and quickly respond to changes in the orientation of the field to maintain cathodal movement. Through a behavioral screen, we identified a subset of sensory neurons located at the tip of the larval head that are necessary for electrotaxis. Calcium imaging revealed that a pair of Gr66a-positive sensory neurons (one on each side of the head) encodes the strength and orientation of the electric field. Our results indicate that electric fields elicit robust behavioral and neural responses in the Drosophila larva, providing new evidence for the significance of electrosensation in invertebrates., This work was funded by the University of California, Santa Barbara (startup funds), the Spanish Ministry of Science and Innovation (MICINN, BFU2008-00362, BFU2009-07757-E/BMC, and BFU2011-26208), the “Centro de Excelencia Severo Ochoa 2013–2017,” the CERCA Programme/Generalitat de Catalunya, and the EMBL/CRG Systems Biology Program. K.W.’s work is supported by the National Institutes of Health (3R01NS054814).
Repisalud
Publicación Artículo científico (JournalArticle)

Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.

  • Mateo, F
  • Arenas, E J
  • Aguilar, H
  • Serra-Musach, J
  • de Garibay, G Ruiz
  • Boni, J
  • Maicas, M
  • Du, S
  • Iorio, F
  • Herranz-Ors, C
  • Islam, A
  • Prado, X
  • Llorente, A
  • Petit, A
  • Vidal, A
  • Català, I
  • Soler, T
  • Venturas, G
  • Rojo-Sebastian, A
  • Serra, H
  • Cuadras, D
  • Blanco, I
  • Lozano, J
  • Canals, F
  • Sieuwerts, A M
  • de Weerd, V
  • Look, M P
  • Puertas, S
  • García, N
  • Perkins, A S
  • Bonifaci, N
  • Skowron, M
  • Gómez-Baldó, L
  • Hernández, V
  • Martínez-Aranda, A
  • Martínez-Iniesta, M
  • Serrat, X
  • Cerón, J
  • Brunet, J
  • Barretina, M P
  • Gil, M
  • Falo, C
  • Fernández, A
  • Morilla, I
  • Pernas, S
  • Plà, M J
  • Andreu, X
  • Seguí, M A
  • Ballester, R
  • Castellà, E
  • Nellist, M
  • Morales, S
  • Valls, J
  • Velasco, A
  • Matias-Guiu, X
  • Figueras, A
  • Sánchez-Mut, J V
  • Sánchez-Céspedes, M
  • Cordero, A
  • Gómez-Miragaya, J
  • Palomero, L
  • Gómez, A
  • Gajewski, T F
  • Cohen, E E W
  • Jesiotr, M
  • Bodnar, L
  • Quintela-Fandino, M
  • López-Bigas, N
  • Valdés-Mas, R
  • Puente, X S
  • Viñals, F
  • Casanovas, O
  • Graupera, M
  • Hernández-Losa, J
  • Ramón Y Cajal, S
  • García-Alonso, L
  • Saez-Rodriguez, J
  • Esteller, M
  • Sierra, A
  • Martín-Martín, N
  • Matheu, A
  • Carracedo, A
  • González-Suárez, E
  • Nanjundan, M
  • Cortés, J
  • Lázaro, C
  • Odero, M D
  • Martens, J W M
  • Moreno-Bueno, G
  • Barcellos-Hoff, M H
  • Villanueva, A
  • Gomis, R R
  • Pujana, M A
Inhibitors of the mechanistic target of rapamycin (mTOR) are currently used to treat advanced metastatic breast cancer. However, whether an aggressive phenotype is sustained through adaptation or resistance to mTOR inhibition remains unknown. Here, complementary studies in human tumors, cancer models and cell lines reveal transcriptional reprogramming that supports metastasis in response to mTOR inhibition. This cancer feature is driven by EVI1 and SOX9. EVI1 functionally cooperates with and positively regulates SOX9, and promotes the transcriptional upregulation of key mTOR pathway components (REHB and RAPTOR) and of lung metastasis mediators (FSCN1 and SPARC). The expression of EVI1 and SOX9 is associated with stem cell-like and metastasis signatures, and their depletion impairs the metastatic potential of breast cancer cells. These results establish the mechanistic link between resistance to mTOR inhibition and cancer metastatic potential, thus enhancing our understanding of mTOR targeting failure.
Repisalud
Publicación Artículo científico (JournalArticle)

The mitochondrial Na/Ca exchanger NCLX is implied in the activation of hypoxia-inducible factors.

  • Choya-Foces, Carmen
  • Navarro, Elisa
  • Ríos, Cristóbal de Los
  • López, Manuela G
  • Egea, Javier
  • Hernansanz-Agustín, Pablo
  • Martínez-Ruiz, Antonio
Eukaryotic cells and organisms depend on oxygen for basic living functions, and they display a panoply of adaptations to situations in which oxygen availability is diminished (hypoxia). A number of these responses in animals are mediated by changes in gene expression programs directed by hypoxia-inducible factors (HIFs), whose main mechanism of stabilization and functional activation in response to decreased cytosolic oxygen concentration was elucidated two decades ago. Human acute responses to hypoxia have been known for decades, although their precise molecular mechanism for oxygen sensing is not fully understood. It is already known that a redox component, linked with reactive oxygen species (ROS) production of mitochondrial origin, is implied in these responses. We have recently described a mechanism by which the mitochondrial sodium/calcium exchanger, NCLX, participates in mitochondrial electron transport chain regulation and ROS production in response to acute hypoxia. Here we show that NCLX is also implied in the response to hypoxia mediated by the HIFs. By using a NCLX inhibitor and interference RNA we show that NCLX activity is necessary for HIF-α subunits stabilization in hypoxia and for HIF-1-dependent transcriptional activity. We also show that hypoxic mitochondrial ROS production is not required for HIF-1α stabilization under all circumstances, suggesting that the basal cytosolic redox state or other mechanism(s) could be operating in the NCLX-mediated response to hypoxia that operates through HIF-α stabilization. This finding provides a link between acute and medium-term responses to hypoxia, reinforcing a central role of mitochondrial cell signalling in the response to hypoxia.
Repisalud
Publicación Artículo científico (JournalArticle)

Burden of postmenopausal breast cancer attributable to excess body weight: comparative study of body mass index and CUN-BAE in MCC-Spain study

  • Cubelos-Fernández, Naiara
  • Dávila-Batista, Verónica
  • Fernández-Villa, Tania
  • Castaño-Vinyals, Gemma
  • Perez-Gomez, Beatriz
  • Amiano, Pilar
  • Ardanaz, Eva
  • Delgado Sillero, Irene
  • Llorca, Javier
  • Tardón, Guillermo Fernández
  • Alguacil, Juan
  • Vanaclocha-Espi, Mercedes
  • Marcos-Gragera, Rafael
  • Moreno, Victor
  • Aragones, Nuria
  • Dorronsoro, Ane
  • Guevara, Marcela
  • Reguero Celada, Sofía
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Martín, Vicente
Background: 10% of postmenopausal breast cancer cases are attributed to a high body mass index (BMI). BMI underestimates body fat, particularly in older women, and therefore the cancer burden attributable to obesity may be even higher. However, this is not clear. CUN-BAE (Clínica Universidad de Navarra-Body Adiposity Estimator) is an accurate validated estimator of body fat, taking into account sex and age. The objective of this study was to compare the burden of postmenopausal breast cancer attributable to excess body fat calculated using BMI and CUN-BAE. Methods: This case-control study included 1033 cases of breast cancer and 1143 postmenopausal population controls from the multicase-control MCC-Spain study. Logistic regression models were used to calculate odds ratios (ORs). The population attributable fraction (PAF) of excess weight related to breast cancer was estimated with both anthropometric measures. Stratified analyses were carried out for hormone receptor type. Results: Excess body weight attributable to the risk of breast cancer was 23.0% when assessed using a BMI value ≥30 kg/m2 and 38.0% when assessed using a CUN-BAE value of ≥40% body fat. Hormone receptor stratification showed that these differences in PAFs were only observed in hormone receptor positive cases, with an estimated burden of 19.9% for BMI and 41.9% for CUN-BAE. Conclusion: These findings suggest that the significance of excess body fat in postmenopausal hormone receptor positive breast cancer could be underestimated when assessed using only BMI. Accurate estimation of the cancer burden attributable to obesity is crucial for planning effective prevention initiatives.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Bragg Gratings Inscribed in Solid-Core Microstructured Single-Mode Polymer Optical Fiber Drawn From a 3D-Printed Polycarbonate Preform

  • Zubel, Michal G.
  • Fasano, Andrea
  • Woyessa, Getinet Taffesse
  • Min, Rui
  • Leal-Junior, Arnaldo Gomes
  • Theodosiou, Antreas
  • Marques, Carlos A. F.
  • Rasmussen, Henrik K.
  • Bang, Ole
  • Kalli, Kyriacos
  • Frizera-Neto, Anselmo
  • Pontes, Maria Jose
  • Sugden, Kate
  • Ortega Tamarit, Beatriz|||0000-0003-1196-4756
[EN] This paper reports the first microstructured solid-core fiber drawn from a 3D-printed preform and the first fiber Bragg gratings inscribed in a fiber of this type. The presented fiber is made of polycarbonate and displays single-mode behavior. The fiber attenuation was the lowest reported so far for a POF drawn from a 3D-printed preform across a broad range of wavelengths. In addition, extensive fiber characterization results are presented and discussed including: fiber attenuation, mode simulations, dynamic thermomechanical analysis and thermo-optic coefficient. Fiber Bragg gratings are successfully inscribed in the produced fiber using three different lasers: a continuous wave helium-cadmium laser, a pulsed femtosecond frequency doubled ytterbium laser and ultra-violet nanosecond krypton fluoride laser. Mechanical testing of the fiber showed that the 3D printing approach did not introduce any unexpected or undesirable characteristics., This work was supported by the People Program (Marie Curie Actions) of the European Union's Seventh Framework Program FP7/2007-2013/, through Research Executive Agency (REA), under Grant 608382. The work of Carlos A. F. Marques was supported in part by the Fundacao para a Ciencia e a Tecnologia (FCT) under Grant UID/EEA/50008/2013, Grant UID/CTM/50025/2019, and Grant SAICTPAC/0036/2015, in part by the National Funds through the FCT/Ministerio da Educacao e Ciencia, in part by the European Regional Development Fund, through the PT2020 Partnership, and in part by national funds (OE), through FCT, in the scope of the framework contract foreseen in the numbers 4, 5, and 6 of the article 23 (Decree-Law 57/2016, August 29, changed by Law 57/2017, July 19).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

miRNA detection methods and clinical implications in lung cancer

  • Usó, Marta
  • Bremnes, Roy M.
  • Camps, Carlos
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
  • Sirera Pérez, Rafael|||0000-0001-9162-8490
[EN] Lung cancer is the leading cause of cancer death worldwide. Therefore, advances in the diagnosis and treatment of the disease are urgently needed. miRNAs are a family of small, noncoding RNAs that regulate gene expression at the transcriptional level. miRNAs have been reported to be deregulated and to play a critical role in different types of cancer, including lung cancer. Thus, miRNA profiling in lung cancer patients has become the core of several investigations. To this end, the development of a multitude of platforms for miRNA profiling analysis has been essential. This article focuses on the different technologies available for assessing miRNAs and the most important results obtained to date in lung cancer., This study was partially supported by a grant from the Ministerio de Ciencia e Inovacion de Espana (TRA09-0132), Beca Roche en Onco-Hematologia 2009 and Red Tematica de Investigacion Cooperativa en Cancer (RD12/0036/0025). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Automated Glioblastoma Segmentation Based on a Multiparametric Structured Unsupervised Classification

  • Juan Albarracín, Javier
  • Robles Viejo, Montserrat
  • Aparici, F.
  • Marti-Bonmati, L.
  • Fuster García, Elíes|||0000-0002-0716-8960
  • Manjón Herrera, José Vicente|||0000-0001-6640-927X
  • Garcia-Gomez, Juan M
Automatic brain tumour segmentation has become a key component for the future of brain tumour treatment. Currently, most of brain tumour segmentation approaches arise from the supervised learning standpoint, which requires a labelled training dataset from which to infer the models of the classes. The performance of these models is directly determined by the size and quality of the training corpus, whose retrieval becomes a tedious and time-consuming task. On the other hand, unsupervised approaches avoid these limitations but often do not reach comparable results than the supervised methods. In this sense, we propose an automated unsupervised method for brain tumour segmentation based on anatomical Magnetic Resonance (MR) images. Four unsupervised classification algorithms, grouped by their structured or non-structured condition, were evaluated within our pipeline. Considering the non-structured algorithms, we evaluated K-means, Fuzzy K-means and Gaussian Mixture Model (GMM), whereas as structured classification algorithms we evaluated Gaussian Hidden Markov Random Field (GHMRF). An automated postprocess based on a statistical approach supported by tissue probability maps is proposed to automatically identify the tumour classes after the segmentations. We evaluated our brain tumour segmentation method with the public BRAin Tumor Segmentation (BRATS) 2013 Test and Leaderboard datasets. Our approach based on the GMM model improves the results obtained by most of the supervised methods evaluated with the Leaderboard set and reaches the second position in the ranking. Our variant based on the GHMRF achieves the first position in the Test ranking of the unsupervised approaches and the seventh position in the general Test ranking, which confirms the method as a viable alternative for brain tumour segmentation., EFG was supported by Programa Torres Quevedo, Ministerio de Educacion y Ciencia, co-funded by the European Social Fund (PTQ-1205693). EFG, JMGG, and JVM were supported by Red Tematica de Investigacion Cooperativa en Cancer, (RTICC) 2013-2016 (RD12/0036/0020). JMGG was supported by Project TIN2013-43457-R: Caracterizacion de firmas biologicas de glioblastomas mediante modelos no-supervisados de prediccion estructurada basados en biomarcadores de imagen, co-funded by the Ministerio de Economia y Competitividad of Spain; CON2014001 UPV-IISLaFe: Unsupervised glioblastoma tumor components segmentation based on perfusion multiparametric MRI and spatio/temporal constraints; and CON2014002 UPV-IISLaFe: Empleo de segmentacion no supervisada multiparametrica basada en perfusion RM para la caracterizacion del edema peritumoral de gliomas y metastasis cerebrales unicas, funded by Instituto de Investigacion Sanitaria H. Universitario y Politecnico La Fe. This work was partially supported by the Instituto de Aplicaciones de las Tecnologias de la Informacion y las Comunicaciones Avanzadas (ITACA). Veratech for Health S.L. provided support in the form of salaries for author EF-G, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the "author contributions" section. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Urinary Metabolic Signatures Detect Recurrences in Non-Muscle Invasive Bladder Cancer

  • Loras, Alba
  • Quintás, Guillermo
  • Gil Grau, Salvador
  • Ruiz-Cerdá, José Luis
  • Martínez-Bisbal, M.Carmen|||0000-0002-8526-4413
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Patients with non-muscle invasive bladder cancer (NMIBC) undergo lifelong monitoring based on repeated cystoscopy and urinary cytology due to the high recurrence rate of this tumor. Nevertheless, these techniques have some drawbacks, namely, low accuracy in detection of low-grade tumors, omission of pre-neoplastic lesions and carcinomas in situ (CIS), invasiveness, and high costs. This work aims to identify a urinary metabolomic signature of recurrence by proton Nuclear Magnetic Resonance (H-1 NMR) spectroscopy for the follow-up of NMIBC patients. To do this, changes in the urinary metabolome before and after transurethral resection (TUR) of tumors are analyzed and a Partial Least Square Discriminant Analysis (PLS-DA) model is developed. The usefulness of this discriminant model for the detection of tumor recurrences is assessed using a cohort of patients undergoing monitoring. The trajectories of the metabolomic profile in the follow-up period provide a negative predictive value of 92.7% in the sample classification. Pathway analyses show taurine, alanine, aspartate, glutamate, and phenylalanine perturbed metabolism associated with NMIBC. These results highlight the potential of H-1 NMR metabolomics to detect bladder cancer (BC) recurrences through a non-invasive approach., This work was partly supported by the financial support of FEDER cofounded MINECO grant NANOPROBE, MAT2015-64139-C4-1-R, MAT2015-64139-C4-2-R, RTI2018-100910-B-C41 and RTI2018-100910-B-C43 (MCUI/AEI/FEDER, UE), ISCIII-RETICRD12/0036/0009, CTQ2016-79561-P, PROMETEO II/2014/047 and PROMETEO 2018/024. A.L. acknowledges a predoctoral grant from the Generalitat Valenciana (VALI+D ACIF/2015/115).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Investigation of Complement Activation Product C4d as a Diagnostic and Prognostic Biomarker for Lung Cancer

  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
[EN] Background There is a medical need for diagnostic biomarkers in lung cancer. We evaluated the diagnostic performance of complement activation fragments. Methods We assessed complement activation in four bronchial epithelial and seven lung cancer cell lines. C4d, a degradation product of complement activation, was determined in 90 primary lung tumors; bronchoalveolar lavage supernatants from patients with lung cancer (n = 50) and nonmalignant respiratory diseases (n = 22); and plasma samples from advanced (n = 50) and early lung cancer patients (n = 84) subjects with inflammatory lung diseases (n = 133), and asymptomatic individuals enrolled in a lung cancer computed tomography screening program (n = 190). Two-sided P values were calculated by Mann-Whitney U test. Results Lung cancer cells activated the classical complement pathway mediated by C1q binding that was inhibited by phosphomonoesters. Survival was decreased in patients with high C4d deposition in tumors (hazard ratio [HR] = 3.06; 95% confidence interval [CI] = 1.18 to 7.91). C4d levels were increased in bronchoalveolar lavage fluid from lung cancer patients compared with patients with nonmalignant respiratory diseases (0.61 +/- 0.87 vs 0.16 +/- 0.11 mu g/mL; P < .001). C4d levels in plasma samples from lung cancer patients at both advanced and early stages were also increased compared with control subjects (4.13 +/- 2.02 vs 1.86 +/- 0.95 mu g/mL, P < 0.001; 3.18 +/- 3.20 vs 1.13 +/- 0.69 mu g/mL, P < .001, respectively). C4d plasma levels were associated with shorter survival in patients at advanced (HR = 1.59; 95% CI = 0.97 to 2.60) and early stages (HR = 5.57; 95% CI = 1.60 to 19.39). Plasma C4d levels were reduced after surgical removal of lung tumors (P < .001) and were associated with increased lung cancer risk in asymptomatic individuals with (n = 32) or without lung cancer (n = 158) (odds ratio = 4.38; 95% CI = 1.61 to 11.93). Conclusions Complement fragment C4d may serve as a biomarker for early diagnosis and prognosis of lung cancer., This work was supported by UTE project CIMA; the Spanish Government (grant numbers ISCIII-RTICC RD06/0020/0066, RD06/0020/1024, RD12/0036/0025, RD12/0036/0040, RD12/0036/0062, PI08/0923, PI10/01652, PI10/00166, and PI11/00618); the European Regional Development Fund; the European Community’s Seventh Framework Programme (HEALTH-F2-2010-258677- CURELUNG); and the Early Detection Research Network from the National Cancer Institute (grant number U01 CA152662). This work was supported (in part) by a grant (RD12/0036/XXXX) from Red Temática de Investigación Cooperativa en Cáncer, Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness & European Regional Development Fund “Una manera de hacer Europa”.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Analysis of the prognostic role of an immune checkpoint score in resected non-small cell lung cancer patients

  • Usó, Marta
  • Calabuig-Farinas, Silvia
  • Blasco, Ana
  • Garcia del Olmo, Eva
  • Guijarro, Ricardo
  • Martorell, Miguel
  • Camps, Carlos
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
  • Sirera Pérez, Rafael|||0000-0001-9162-8490
[EN] Tumors develop mechanisms to recruit tolerogenic immune cells and to induce the expression of molecules that act as immune checkpoints. This regulation of the immune microenvironment favors immune tolerance to the neoplastic cells. In this study, we have investigated the prognostic role of immune-checkpoint expression markers in a cohort of resectable non-small cell lung cancer (NSCLC) patients. RNA was isolated from fresh-frozen lung specimens (tumor and normal lung) (n = 178). RTqPCR was performed to analyze the relative expression of 20 immune-related genes that were normalized by the use of endogenous genes selected by GeNorm algorithm. Patients with higher expression levels of IL23A and LGALS2 presented better outcomes. In the clustering expression patterns, we observed that patients with higher expression of immunoregulatory genes had better survival rates. Additionally, these data were used to develop a gene expression score. Since CTLA4 and PD1 were associated with prognosis based on Cox regression analysis (Z-score > 1.5), a multivariate model including these two genes was created. Absolute regression coefficients from this analysis were used in order to calculate the immunecheckpoint score: (PD1 x 0.116) + (CTLA4 x 0.059) for each case. Kaplan-Meier survival analysis showed that patients with high immune-checkpoint score have longer overall survival (OS) [NR vs. 40.4 mo, p = 0.008] and longer relapse-free survival (RFS) [82.6 vs. 23 mo, p = 0.009]. Multivariate analysis in the entire cohort indicated that the immune-checkpoint score was an independent biomarker of prognosis for OS [HR: 0.308; 95% CI, 0.156-0.609; p = 0.001] and RFS [HR: 0.527; 95% CI, 0.298-0.933; p = 0.028] in early-stage NSCLC patients. In conclusion, this score provides relevant prognostic information for a better characterization of early stage NSCLS patients with strikingly different outcomes and who may be candidates for immune-based therapies., This work was supported by the Red Tematica de Investigacion Cooperativa en Cancer (RD12/0036/0025) and the Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional (PI09/01147, PI09/01149 and PI12/02838)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

MicroRNAs: Promising New Antiangiogenic Targets in Cancer

  • Gallach, Sandra
  • Calabuig-Farinas, Silvia
  • Camps, Carlos
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
[EN] MicroRNAs are one class of small, endogenous, non-coding RNAs that are approximately 22 nucleotides in length; they are very numerous, have been phylogenetically conserved, and involved in biological processes such as development, differentiation, cell proliferation, and apoptosis. MicroRNAs contribute to modulating the expression levels of specific proteins based on sequence complementarity with their target mRNA molecules and so they play a key role in both health and disease. Angiogenesis is the process of new blood vessel formation from preexisting ones, which is particularly relevant to cancer and its progression. Over the last few years, microRNAs have emerged as critical regulators of signalling pathways in multiple cell types including endothelial and perivascular cells. This review summarises the role of miRNAs in tumour angiogenesis and their potential implications as therapeutic targets in cancer., This study was partially supported by a Grant from Ministerio de Ciencia e Inovacion de Espana (TRA09-0132), Beca Roche en Onco-Hematologia 2009, and Red Tematica de Investigacion Cooperativa en Cancer (RD12/0036/0025).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Facilitated Anion Transport Induces Hyperpolarization of the Cell Membrane That Triggers Differentiation and Cell Death in Cancer Stem Cells

  • Soto-Cerrato, Vanessa
  • Manuel-Manresa, Pilar
  • Hernando, Elsa
  • Calabuig-Farinas, Silvia
  • Martinez-Romero, Alicia
  • Fernandez-Dueñas, Victor
  • Sahlholm, Kristoffer
  • Knoepfel, Thomas
  • Garcia-Valverde, Maria
  • Rodilla, Ananda M.
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
  • Farras, Rosa
  • Ciruela, Francisco
  • Perez-Tomas, Ricardo
  • Quesada, Roberto
Facilitated anion transport potentially represents a powerful tool to modulate various cellular functions. However, research into the biological effects of small molecule anionophores is still at an early stage. Here we have used two potent anionophore molecules inspired in the structure of marine metabolites tambjamines to gain insight into the effect induced by these compounds at the cellular level. We show how active anionophores, capable of facilitating the transmembrane transport of chloride and bicarbonate in model phospholipid liposomes, induce acidification of the cytosol and hyperpolarization of plasma cell membranes. We demonstrate how this combined effect can be used against cancer stem cells (CSCs). Hyperpolarization of cell membrane induces cell differentiation and loss of sternness of CSCs leading to effective elimination of this cancer cell subpopulation., This work was supported by grants from the Spanish government and the EU (FIS PI13/00089, PIS PI12/02838, FIS PI12/00956 and RD12/0036/0025), a grant from La Marato de TV3 Foundation (20132730), a grant from SEPAR (17/2014), Consejeria de Educacion de la Junta de Castilla y Leon (Project BU340U13), Ministerio de Economia y competitividad/Instituto de Salud Carlos III (SAF2014-55700-P), and ICREA Academia-2010. E.H. thanks the Junta de Castilla y Leon (Consejeria de Educacion) and the Fondo Social Europeo for a PIRTU contract. We thank Benjamin Torrejon and Esther Castano from CCiT (Centres Cientifics i Tecnologics, Campus de Bellvitge, Universitat de Barcelona), Sandra Tejedor (Centro de Investigacion Principe Felipe), Luis Korrodi-Gregorio (UB), and Andrea Sancho (UBU) for their technical support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Integrative Metabolomic and Transcriptomic Analysis for the Study of Bladder Cancer

  • Loras, Alba
  • Suárez-Cabrera, Cristian
  • Quintás, Guillermo
  • Paramio, Jesús M.
  • Gil Grau, Salvador
  • Ruiz-Cerdá, José Luis
  • Martínez-Bisbal, M.Carmen|||0000-0002-8526-4413
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Metabolism reprogramming is considered a hallmark of cancer. The study of bladder cancer (BC) metabolism could be the key to developing new strategies for diagnosis and therapy. This work aimed to identify tissue and urinary metabolic signatures as biomarkers of BC and get further insight into BC tumor biology through the study of gene-metabolite networks and the integration of metabolomics and transcriptomics data. BC and control tissue samples (n = 44) from the same patients were analyzed by High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance and microarrays techniques. Besides, urinary profiling study (n = 35) was performed in the same patients to identify a metabolomic profile, linked with BC tissue hallmarks, as a potential non-invasive approach for BC diagnosis. The metabolic profile allowed for the classification of BC tissue samples with a sensitivity and specificity of 100%. The most discriminant metabolites for BC tissue samples reflected alterations in amino acids, glutathione, and taurine metabolic pathways. Transcriptomic data supported metabolomic results and revealed a predominant downregulation of metabolic genes belonging to phosphorylative oxidation, tricarboxylic acid cycle, and amino acid metabolism. The urinary profiling study showed a relation with taurine and other amino acids perturbed pathways observed in BC tissue samples, and classified BC from non-tumor urine samples with good sensitivities (91%) and specificities (77%). This urinary profile could be used as a non-invasive tool for BC diagnosis and follow-up., This research was funded by FEDER cofounded MINECO grant SAF2015-66015-R, MAT2015-64139-C4-1-R, MAT2015-64139-C4-3-R, ISCIII-RETICRD12/0036/0009, PIE 15/00076, CB/16/00228, CTQ2016-79561-P; and the PROMETEO II/2014/047 and PROMETEO 2018/24 projects.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Application of Artificial Neural Network for Reducing Random Coincidences in PET

  • Oliver, J,F.
  • Cabello, J.
  • Tortajada Velert, Salvador
  • Rafecas Lopez, Maria Magdalena
  • Fuster García, Elíes|||0000-0002-0716-8960
Positron Emission Tomography (PET) is based on the detection in coincidence of the two photons created in a positron annihilation. In conventional PET, this coincidence identification is usually carried out through a coincidence electronic unit. An accidental coincidence occurs when two photons arising from different annihilations are classified as a coincidence. Accidental coincidences are one of the main sources of image degradation in PET. Some novel systems allow coincidences to be selected post-acquisition in software, or in real time through a digital coincidence engine in an FPGA. These approaches provide the user with extra flexibility in the sorting process and allow the application of alternative coincidence sorting procedures. In this work a novel sorting procedure based on Artificial Neural Network (ANN) techniques has been developed. It has been compared to a conventional coincidence sorting algorithm based on a time coincidence window. The data have been obtained from Monte-Carlo simulations. A small animal PET scanner has been implemented to this end. The efficiency (the ratio of correct identifications) can be selected for both methods. In one case by changing the actual value of the coincidence window used, and in the other by changing a threshold at the output of the neural network. At matched efficiencies, the ANN-based method always produces a sorted output with a smaller random fraction. In addition, two differential trends are found: the conventional method presents a maximum achievable efficiency, while the ANN-based method is able to increase the efficiency up to unity, the ideal value, at the cost of increasing the random fraction. Images reconstructed using ANN sorted data (no compensation for randoms) present better contrast, and those image features which are more affected by randoms are enhanced. For the image quality phantom used in the paper, the ANN method decreases the spillover ratio by a factor of 18%., This work was supported by RD12/0036/0020 Red Tematica de Investigacion Coperativa en Cancer (RTICC) 2012; Ministerio de Ciencia e Innovacion through a JAE-Doc contract associated to CSIC and FSE co-financed; also under projects TEC-2007-61047 and FPA-2010-14891.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

MicroRNA profiling associated with non-small cell lung cancer: next generation sequencing detection, experimental validation, and prognostic value

  • Gallach-Garcia, Sandra
  • Calabuig-Fariñas, Silvia
  • Montaner, David
  • Alonso, Sergio
  • Blasco, Ana
  • Usó-Marco, Marta
  • Guijarro, Ricardo
  • Martorell, Miguel
  • Camps-Herrero, Carlos
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
  • Sirera Pérez, Rafael|||0000-0001-9162-8490
[EN] Background: The average five-year survival for non-small cell lung cancer (NSCLC) patients is approximately 15%. Emerging evidence indicates that microRNAs (miRNAs) constitute a new class of gene regulators in humans that may play an important role in tumorigenesis. Hence, there is growing interest in studying their role as possible new biomarkers whose expression is aberrant in cancer. Therefore, in this study we identified dysregulated miRNAs by next generation sequencing (NGS) and analyzed their prognostic value. Methods: Sequencing by oligo ligation detection technology was used to identify dysregulated miRNAs in a training cohort comprising paired tumor/normal tissue samples (N = 32). We validated 22 randomly selected differentially-expressed miRNAs by quantitative real time PCR in tumor and adjacent normal tissue samples (N = 178). Kaplan-Meier survival analysis and Cox regression were used in multivariate analysis to identify independent prognostic biomarkers. Results: NGS analysis revealed that 39 miRNAs were dysregulated in NSCLC: 28 were upregulated and 11 were downregulated. Twenty-two miRNAs were validated in an independent cohort. Interestingly, the group of patients with high expression of both miRNAs (miR-21(high) and miR-188(high)) showed shorter relapse-free survival (RFS) and overall survival (OS) times. Multivariate analysis confirmed that this combined signature is an independent prognostic marker for RFS and OS (p = 0.001 and p < 0.0001, respectively). Conclusions: NGS technology can specifically identify dysregulated miRNA profiles in resectable NSCLC samples. MiR-21 or miR-188 overexpression correlated with a negative prognosis, and their combined signature may represent a new independent prognostic biomarker for RFS and OS., This work was supported by the RD12/0036/0025 and RD06/0020/1024 PI12-02838, ISCIII, grants from the Fondo Europeo de Desarrollo Regional (FEDER), by funds from the Proyecto de Investigacion Fundamental Orientada a la Transmision de Conocimiento a la Empresa (TRACE; TRA09-0132) and Beca Roche Oncohematologia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers

  • Usó-Marco, Marta
  • Bremnes, Roy M.
  • Calabuig-Fariñas, Silvia
  • Blasco-Cordellat, Ana
  • Pastor, Enrique
  • Borreda, Irene
  • Molina-Pinelo, Sonia
  • Paz-Ares, Luis
  • Guijarro, Ricardo
  • Martorell, Miguel
  • Forteza, Jerónimo
  • Camps-Herrero, Carlos
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
  • Sirera Pérez, Rafael|||0000-0001-9162-8490
[EN] The prognosis of non-small cell lung cancer (NSCLC) remains poor and heterogeneous and new biomarkers are needed. As the immune system plays a pivotal role in cancer, the study of immune-related markers may provide valuable prognostic information of NSCLC. In 122 formalin-fixed, paraffin-embedded tumor tissue samples from early-stage NSCLC, tumor and tumor-near stromal areas were microdissected and gene expression levels of conventional and regulatory T cell markers were assessed by quantitative polymerase chain reaction. Also, the presence of infiltrating CD4+, CD8+, and FOXP3+ cells in tumor samples was assessed by immunohistochemistry. The relative proportion of conventional and regulatory T cells present in the tumor environment was assessed and found to be key to understand the importance that the immune system analysis has in the prognostics of NSCLC patients. The presence of CD8+ cells in the tumor compartment was associated with better outcome, whereas the presence of FOXP3+ cells was associated with worse overall survival. The negative prognostic value of combined biomarkers, indicating high levels of FOXP3 in the stroma and low levels of CD4 or CD8 in tumors, was observed at mRNA level and was validated by immunohistochemistry. In conclusion, the proportion of T helper and cytotoxic cells vs. regulatory T cells in different locations of the tumor microenvironment have opposite prognostic impacts in resected NSCLC., This work was supported by the Red Temática de Investigación Cooperativa en Cáncer (RD12/0036/0025) and the Fondo de Investigación Sanitaria-Fondo Europeo de Desarrollo Regional (PI09/01147, PI09/01149 and PI12/02838).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Identification of TRPC6 as a possible candidate target gene within an amplicon at 11q21-q22.2 for migratory capacity in head and neck squamous cell carcinomas

  • Bernaldo de Quirós, Sandra
  • Merlo, Anna
  • Secades, Pablo
  • Zambrano, Iriana
  • Saenz de Santa María, Inés
  • Ugidos, Nerea
  • Suarez, Carlos
  • Chiara, Maria Dolores
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
  • Sirera Pérez, Rafael|||0000-0001-9162-8490
Abstract: Background: Cytogenetic and gene expression analyses in head and neck squamous cell carcinomas (HNSCC) have allowed identification of genomic aberrations that may contribute to cancer pathophysiology. Nevertheless, the molecular consequences of numerous genetic alterations still remain unclear. Methods: To identify novel genes implicated in HNSCC pathogenesis, we analyzed the genomic alterations present in five HNSCC-derived cell lines by array CGH, and compared high level focal gene amplifications with gene expression levels to identify genes whose expression is directly impacted by these genetic events. Next, we knocked down TRPC6, one of the most highly amplified and over-expressed genes, to characterize the biological roles of TRPC6 in carcinogenesis. Finally, real time PCR was performed to determine TRPC6 gene dosage and mRNA levels in normal mucosa and human HNSCC tissues. Results: The data showed that the HNSCC-derived cell lines carry most of the recurrent genomic abnormalities previously described in primary tumors. High-level genomic amplifications were found at four chromosomal sites (11q21-q22.2, 18p11.31-p11.21, 19p13.2-p13.13, and 21q11) with associated gene expression changes in selective candidate genes suggesting that they may play an important role in the malignant behavior of HNSCC. One of the most dramatic alterations of gene transcription involved the TRPC6 gene (located at 11q21-q22.2) which has been recently implicated in tumour invasiveness. siRNA-induced knockdown of TRPC6 expression in HNSCC-derived cells dramatically inhibited HNSCC-cell invasion but did not significantly alter cell proliferation. Importantly, amplification and concomitant overexpression of TRPC6 was also found in HNSCC tumour samples. Conclusions: Altogether, these data show that TRPC6 is likely to be a target for 11q21-22.2 amplification that confers enhanced invasive behavior to HNSCC cells. Therefore, TRPC6 may be a promising therapeutic target in the treatment of HNSCC., This work was supported by Instituto de Salud Carlos III-Fondo de Investigacion Sanitaria [FIS PI11/929 to M.-D.C and C. S.]; Red Tematica de Investigacion Cooperativa en Cancer [RD12/0036/0015] Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness & European Regional Development Fund (ERDF); and Obra Social CajAstur-Instituto Universitario de Oncologia del Principado de Asturias.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma

  • Ajona, D.
  • Pajares, M. J.
  • Chiara, M. D.
  • Rodrigo, J. P.
  • Camps, C.
  • Suarez, C.
  • Bagan, J. V.
  • Montuenga, L. M.
  • Pio, R.
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
OBJECTIVE: Complement C4d-containing fragments have been proposed as diagnostic markers for lung cancer. The purpose of this study was to evaluate the presence of C4d in oropharyngeal (OPSCC) and oral (OSCC) squamous cell carcinomas. SUBJECTS AND METHODS: C4d staining was analyzed by immunohistochemistry in 244 OPSCC surgical specimens. C4d levels were quantified by ELISA in resting saliva samples from 48 patients with oral leukoplakia and 62 with OSCC. Plasma samples from 21 patients with leukoplakia and 30 with oral carcinoma were also studied. RESULTS: C4d staining in OPSCC specimens was associated with nodal invasion (P = 0.001), histopathologic grade (P = 0.014), disease stage (P = 0.040), and focal-adhesion kinase expression (P < 0.001). No association was found between C4d and prognosis. Saliva C4d levels were higher in patients with oral cancer than in subjects with leukoplakia (0.07 +/- 0.07 vs 0.04 +/- 0.03 mu g ml(-1), P = 0.003). The area under the ROC curve was 0.63 (95%CI: 0.55-0.71). Salivary C4d levels in stage IV patients were higher than in patients with earlier stages (P = 0.028) and correlated with tumor size (P = 0.045). Plasma C4d levels also correlated with salivary C4d levels (P = 0.041), but differences between patients with oral cancer and subjects with leukoplakia were not significant (1.26 +/- 0.59 vs 1.09 +/- 0.39 mu g ml(-1), P = 0.232). CONCLUSION: C4d-containing fragments are detected in oral primary tumors and are increased in saliva from patients with OSCC., We thank Amaya Lavin for technical assistance. This work was supported by Foundation for Applied Medical Research (FIMA), Red Tematica de Investigacion Cooperativa en Cancer (RD12/0036/0015, RD12/0036/0025, and RD12/0036/0040), and Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional (FEDER, PI11/00618, PI13/00806, PI11/00929, and PI14/01686).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A translational approach to assess the metabolomic impact of stabilized gold nanoparticles by NMR spectroscopy

  • Herance, Jose Raul
  • Guitierrez Carcedo, Patricia
  • Pineda-Lucena, Antonio
  • Palomino-Schätzlein, M.
  • García Gómez, Hermenegildo|||0000-0002-9664-493X
  • Navalón Oltra, Sergio|||0000-0001-8423-0759
[EN] Gold nanoparticles have high potential in the biomedical area, especially in disease diagnosis and treatment. The application of these nanoparticles requires the presence of stabilizers to avoid their agglomeration. Nowadays, there is a lack of reliable methods for characterising the effect of stabilised nanoparticles on biological systems. To this end, in this study, we apply an experimental approach based on nuclear magnetic resonance spectroscopy to study the effect of gold nanoparticles, stabilised with cerium oxide or chitosan, on a human cancer cell model. The results showed that both systems have a significant effect, even at non-toxic levels, on the cellular antioxidant system. However, although particles functionalised with chitosan exerted a strong effect on the aerobic respiration, nanoparticles stabilised with cerium oxide had a higher impact on the mechanisms associated with anaerobic energy production. Therefore, even though both systems contained similar gold nanoparticles, the presence of different stabilizers strongly influenced their mode of action and potential applications in biomedicine., This work was supported by the Carlos III Health Institute, the European Regional Development Fund (PI16/02064 and CP13/00252) and the Spanish Ministerio de Economia y Competitividad (SAF2014-53977-R, SAF2017-89229-R and RD12/0036/0025). In addition, JRH is a recipient of a contract from the Ministry of Health of the Carlos III Health Institute.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Autosomal dominant polycystic kidney disease in young adults

  • Martínez, Víctor
  • Furlano, Mónica
  • Sans, Laia
  • Pulido, Lissett
  • García, Rebeca
  • Pérez Gómez, María Vanessa
  • Sánchez Rodríguez, Jinny
  • Blasco, Miquel
  • Castro Alonso, Cristina
  • Fernández Fresnedo, Gema
  • Roberto Robles, Nicolás
  • Valenzuela, María Pau
  • Naranjo Muñoz, Javier
  • Martín, Nadia
  • Pilco, Melissa
  • Agraz Pamplona, Irene
  • González Rodríguez, Juan David
  • Panizo, Nayara
  • Fraga, Gloria
  • Fernández, Loreto
  • López, María Teresa
  • Dall’Anese, Cecilia
  • Ortiz, Alberto
  • Torra, Roser
Background The clinical manifestations of autosomal dominant polycystic kidney disease (ADPKD) usually appear in adulthood, however pediatric series report a high morbidity. The objective of the study was to analyze the clinical characteristics of ADPKD in young adults. Methods Family history, hypertension, albuminuria, estimated glomerular filtration rate (eGFR) and imaging tests were examined in 346 young adults (18-30 years old) out of 2521 patients in the Spanish ADPKD registry (REPQRAD). A literature review searched for reports on hypertension in series with more than 50 young (age <30 years) ADPKD patients. Results The mean age of this young adult cohort was 25.24 (SD 3.72) years. The mean age at diagnosis of hypertension was 21.15 (SD 4.62) years, while in the overall REPQRAD population was aged 37.6 years. The prevalence of hypertension was 28.03% and increased with age (18-24 years, 16.8%; 25-30 years, 36.8%). Although prevalence was lower in women than in men, the age at onset of hypertension (21 years) was similar in both sexes. Mean eGFR was 108 (SD 21) mL/min/1.73 m(2), 38.0% had liver cysts and 3.45% of those studied had intracranial aneurysms. In multivariate analyses, hematuria episodes and kidney length were independent predictors of hypertension (area under the curve 0.75). The prevalence of hypertension in 22 pediatric cohorts was 20%-40%, but no literature reports on hypertension in young ADPKD adults were found. Conclusions Young adults present non-negligible ADPKD-related morbidity. This supports the need for a thorough assessment of young adults at risk of ADPKD that allows early diagnosis and treatment of hypertension. Lay Summary Impairment of renal function usually develops from the fourth decade of life in autosomal dominant polycystic kidney disease (ADPKD). However, hypertension precedes the onset of renal insufficiency. In published pediatric series, the prevalence of hypertension is 20%-40%. However, clinical information on young adults with ADPKD is scarce. We present the largest cohort of young adults (age 18-30 years) with ADPKD published to date. Prevalence of hypertension is 28% and increases with age, reaching 36.8% in the subgroup aged 25-30 years, despite normal glomerular filtration rate and albuminuria. The prevalence of hypertension is higher in males, but the mean age at diagnosis (21 years) was similar in both sexes. Young adults present non-negligible ADPKD-related morbidity. This supports the need for a thorough assessment that allows early diagnosis and treatment of hypertension, before decline of estimated glomerular filtration rate. Ambulatory blood pressure monitoring may be especially useful in this regard., 11 páginas
Repositorio Institucional de la Universidad de Burgos (RIUBU)
Publicación Artículo científico (JournalArticle)

Best experienced payoff dynamics and cooperation in the centipede game

  • Sandholm, William H.
  • Izquierdo, Segismundo S.
  • Izquierdo Millán, Luis Rodrigo
We study population game dynamics under which each revising agent tests each of his strategies a fixed number of times, with each play of each strategy being against a newly drawn opponent, and chooses the strategy whose total payoff was highest. In the centipede game, these best experienced payoff dynamics lead to cooperative play. When strategies are tested once, play at the almost globally stable state is concentrated on the last few nodes of the game, with the proportions of agents playing each strategy being largely independent of the length of the game. Testing strategies many times leads to cyclical play., U.S. National Science Foundation (Grants SES-1458992 and SES- 1728853), the U.S. Army Research Office (Grants W911NF-17-1-0134 MSN201957), Project ECO2017-83147- C2-2-P (MINECO/AEI/FEDER, UE), and the Spanish Ministerio de Educación, Cultura, y Deporte (Grants PRX15/00362 and PRX16/00048)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Sensation of electric fields in the Drosophila melanogaster larva

  • Tadres, David
  • Riedl, Julia, 1981-
  • Eden, Alexander
  • Bontempo, Angela E.
  • Lin, Jingtong
  • Reid, Samuel F.
  • Roehrich, Brian
  • Williams, Kevin
  • Sepunaru, Lior
  • Louis, Matthieu
Electrosensation has emerged as a crucial sensory modality for social communication, foraging, and predation across the animal kingdom. However, its presence and functional role as well as the neural basis of electric field perception in Drosophila and other invertebrates remain unclear. In environments with controlled electric fields, we identified electrosensation as a new sense in the Drosophila melanogaster larva. We found that the Drosophila larva performs robust electrotaxis: when exposed to a uniform electric field, larvae migrate toward the cathode (negatively charged elecrode) and quickly respond to changes in the orientation of the field to maintain cathodal movement. Through a behavioral screen, we identified a subset of sensory neurons located at the tip of the larval head that are necessary for electrotaxis. Calcium imaging revealed that a pair of Gr66a-positive sensory neurons (one on each side of the head) encodes the strength and orientation of the electric field. Our results indicate that electric fields elicit robust behavioral and neural responses in the Drosophila larva, providing new evidence for the significance of electrosensation in invertebrates., This work was funded by the University of California, Santa Barbara (startup funds), the Spanish Ministry of Science and Innovation (MICINN, BFU2008-00362, BFU2009-07757-E/BMC, and BFU2011-26208), the “Centro de Excelencia Severo Ochoa 2013–2017,” the CERCA Programme/Generalitat de Catalunya, and the EMBL/CRG Systems Biology Program. K.W.’s work is supported by the National Institutes of Health (3R01NS054814).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Species-specific modulation of food-search behavior by respiration and chemosensation in Drosophila larvae

  • Kim, Daeyeon
  • Alvarez, Mar
  • Lechuga, Laura M.
  • Louis, Matthieu
Animals explore their environment to encounter suitable food resources. Despite its vital importance, this behavior puts individuals at risk by consuming limited internal energy during locomotion. We have developed a novel assay to investigate how food-search behavior is organized in Drosophila melanogaster larvae dwelling in hydrogels mimicking their natural habitat. We define three main behavioral modes: resting at the gel's surface, digging while feeding near the surface, and apneic dives. In unstimulated conditions, larvae spend most of their time digging. By contrast, deep and long exploratory dives are promoted by olfactory stimulations. Hypoxia and chemical repellents impair diving. We report remarkable differences in the dig-and-dive behavior of D. melanogaster and the fruit-pest D. suzukii. The present paradigm offers an opportunity to study how sensory and physiological cues are integrated to balance the limitations of dwelling in imperfect environmental conditions and the risks associated with searching for potentially more favorable conditions., We acknowledge support of the Spanish Ministry of Economy and Competitiveness, 'Centro de Excelencia Severo Ochoa 2013-2017', as well as the support of the CERCA Programme/Generalitat de Catalunya. This work was supported by funding from the Spanish Ministry of Science and Innovation (MICINN, BFU2008-00362 and BFU2011-26208), the EMBL/CRG Systems Biology Program and the EU FET-Open grant MINIMAL.
Docta Complutense
Publicación Artículo científico (JournalArticle)

The Five “Ws” of Frailty Assessment and Chronic Lymphocytic Leukemia: Who, What, Where, Why, and When

  • González Gascón y Marín, Isabel
  • Ballesteros Andrés, Mónica
  • Martínez Flores, Sara
  • Rodríguez Vicente, Ana Eugenia
  • Pérez Carretero, Claudia
  • Quijada Álamo, Miguel
  • Rodríguez Sánchez, Alberto
  • Hernández Rivas, José Ángel
Chronic lymphocytic leukemia (CLL) is a disease of the elderly, but chronological age does not accurately discriminate frailty status at the inter-individual level. Frailty describes a person’s overall resilience. Since CLL is a stressful situation, it is relevant to assess the patient´s degree of frailty, especially before starting antineoplastic treatment. We are in the era of targeted therapies, which have helped to control the disease more effectively and avoid the toxicity of chemo (immuno) therapy. However, these drugs are not free of side effects and other aspects arise that should not be neglected, such as interactions, previous comorbidities, or adherence to treatment, since most of these medications are taken continuously. The challenge we face is to balance the risk of toxicity and efficacy in a personalized way and without forgetting that the most frequent cause of death in CLL is related to the disease. For this purpose, comprehensive geriatric assessment (GA) provides us with the opportunity to evaluate multiple domains that may affect tolerance to treatment and that could be improved with appropriate interventions. In this review, we will analyze the state of the art of GA in CLL through the five Ws.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Pharmacological evaluation of non-nucleotide purine derivatives as P2X7 antagonists for the treatment of neuroinflammation in traumatic brain injury.

  • Valencia, Inés
  • Pastor-Martínez, Andrea
  • Decouty-Pérez, Céline
  • Lopez-Rodriguez, Ana Belen
  • Álvarez-Rubal, María
  • Ramos Alonso, Eva
  • Calzaferri, Francesco
  • Zamorano-Fernández, Jorge
  • Giner-García, Javier
  • Palpán-Flores, Alexis J
  • Rodríguez-Domínguez, Víctor
  • Rodríguez de Cía, Javier
  • Hernández-García, Borja J
  • Romero Martínez, Manuel Alejandro
  • de Los Ríos, Cristóbal
  • Egea, Javier
Background and purpose: Traumatic brain injury (TBI) is considered to be a leading cause of mortality and disability worldwide. After TBI, innate immunity is rapidly activated in response to damage-associated molecular patterns, such as ATP release, recognised by P2X7 receptors. The P2X7-NLRP3 inflammasome axis has been identified as one of the main players in neuroinflammation. This study aimed to validate P2X7 receptors as therapeutic target for traumatic brain injury. Experimental approach: P2X7 receptors were studied by genetic and pharmacological approaches. Six non-nucleotide purine derivatives were evaluated as P2X7 antagonists. Compounds that prevented LPS + ATP-induced IL-1β release from primary glial cultures were investigated in the closed-head injury TBI model in vivo in male mice. Finally, we evaluated soluble (s)P2X7 receptor plasmatic levels in a cohort of TBI patients. Key results: P2rx7−/− mice showed an exaggerated inflammatory response 24 h post-TBI compared to control mice. However, animals treated with the selective P2X7 antagonist JNJ-47965567 (30 mg kg−1 i.p.) 30 min post-TBI showed improved neurological and inflammatory parameters. The purine derivative ITH15004 was the most potent compound reducing IL-1β production in vitro. When administered in vivo 30 min post-TBI, ITH15004 (1 mg kg−1 i.p.) improved both neuro-behavioural and inflammatory markers at 24 h. In TBI patients, we showed a tendency towards increase in circulating sP2X7 receptor levels at 24 and 72 h post-TBI. Conclusions and implications: These results highlight the importance of P2X7 receptors in the acute phase of TBI and present ITH15004 as a promising pharmacological tool to counteract P2X7 receptor-dependent neuroinflammation in vivo.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Redox Regulation of Microglial Inflammatory Response: Fine Control of NLRP3 Inflammasome through Nrf2 and NOX4

  • Palomino Antolín, Alejandra
  • Decouty-Pérez, Céline
  • Farré Alins, Víctor
  • Narros Fernández, Paloma
  • López Rodríguez, Ana Belén
  • Álvarez Rubal, María
  • Valencia, Inés
  • López-Muñoz, Francisco
  • Ramos Alonso, Eva
  • Cuadrado, Antonio
  • Casas, Ana I.
  • Romero Martínez, Manuel Alejandro
  • Egea, Javier
The role of inflammation and immunity in the pathomechanism of neurodegenerative diseases has become increasingly relevant within the past few years. In this context, the NOD-like receptor protein 3 (NLRP3) inflammasome plays a crucial role in the activation of inflammatory responses by promoting the maturation and secretion of pro-inflammatory cytokines such as interleukin-1β and interleukin-18. We hypothesized that the interplay between nuclear factor erythroid 2-related factor 2 (Nrf2) and NADPH oxidase 4 (NOX4) may play a critical role in the activation of the NLRP3 inflammasome and subsequent inflammatory responses. After priming mixed glial cultures with lipopolysaccharide (LPS), cells were stimulated with ATP, showing a significant reduction of IL1-β release in NOX4 and Nrf2 KO mice. Importantly, NOX4 inhibition using GKT136901 also reduced IL-1β release, as in NOX4 KO mixed glial cultures. Moreover, we measured NOX4 and NLRP3 expression in wild-type mixed glial cultures following LPS treatment, observing that both increased after TLR4 activation, while 24 h treatment with tert-butylhydroquinone, a potent Nrf2 inducer, significantly reduced NLRP3 expression. LPS administration resulted in significant cognitive impairment compared to the control group. Indeed, LPS also modified the expression of NLRP3 and NOX4 in mouse hippocampus. However, mice treated with GKT136901 after LPS impairment showed a significantly improved discrimination index and recovered the expression of inflammatory genes to normal levels compared with wild-type animals. Hence, we here validate NOX4 as a key player in NLRP3 inflammasome activation, suggesting NOX4 pharmacological inhibition as a potent therapeutic approach in neurodegenerative diseases.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Pharmacological evaluation of non-nucleotide purine derivatives as P2X7 antagonists for the treatment of neuroinflammation in traumatic brain injury

  • Valencia, Inés
  • Pastor-Martínez, Andrea
  • Decouty-Pérez, Céline
  • López-Rodriguez, Ana Belén
  • Álvarez-Rubal, María
  • Ramos Alonso, Eva
  • Calzaferri, Francesco
  • Zamorano-Fernández, Jorge
  • Giner-García, Javier
  • Palpán-Flores, Alexis J
  • Rodriguez-Dominguez, Victor
  • Rodríguez de Cía, Javier
  • Hernández-García, Borja J
  • Romero Martínez, Manuel Alejandro
  • De Los Rios, Cristobal
  • Egea, Javier
Background and purpose: Traumatic brain injury (TBI) is considered to be a leadingcause of mortality and disability worldwide. After TBI, innate immunity is rapidly acti-vated in response to damage-associated molecular patterns, such as ATP release,recognised by P2X7 receptors. The P2X7-NLRP3 inflammasome axis has been identi-fied as one of the main players in neuroinflammation. This study aimed to validateP2X7 receptors as therapeutic target for traumatic brain injury. Experimental approach: P2X7 receptors were studied by genetic and pharmacologi-cal approaches. Six non-nucleotide purine derivatives were evaluated as P2X7 antag-onists. Compounds that prevented LPS + ATP-induced IL-1β release from primaryglial cultures were investigated in the closed-head injury TBI model in vivo in malemice. Finally, we evaluated soluble (s)P2X7 receptor plasmatic levels in a cohort ofTBI patients. Key results: P2rx7 / mice showed an exaggerated inflammatory response 24 hpost-TBI compared to control mice. However, animals treated with the selective P2X7 antagonist JNJ-47965567 (30 mg kg 1 i.p.) 30 min post-TBI showed improvedneurological and inflammatory parameters. The purine derivative ITH15004 was themost potent compound reducing IL-1β production in vitro. When administered in vivo30 min post-TBI, ITH15004 (1 mg kg 1 i.p.) improved both neuro-behavioural andinflammatory markers at 24 h. In TBI patients, we showed a tendency towardsincrease in circulating sP2X7 receptor levels at 24 and 72 h post-TBI. Conclusions and implications: These results highlight the importance of P2X7 recep-tors in the acute phase of TBI and present ITH15004 as a promising pharmacologicaltool to counteract P2X7 receptor-dependent neuroinflammation in vivo.
Docta Complutense
Publicación Artículo científico (JournalArticle)

TRAF3 alterations are frequent in del‐3′IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features

  • Pérez Carretero, Claudia
  • Hernández Rivas, José Ángel
  • Hernández Sánchez, María
  • González, Teresa
  • Quijada Álamo, Miguel
  • Martín Izquierdo, Marta
  • Santos Mínguez, Sandra
  • Miguel García, Cristina
  • Vidal, María Jesús
  • García de Coca, Alfonso
  • Galende, Josefina
  • Pardal, Emilia
  • Aguilar, Carlos
  • Vargas Pabón, Manuel
  • Dávila, Julio
  • Gascón y Marín, Isabel
  • Hernández Rivas, José Ángel
  • Benito, Rocío
  • Rodríguez Vicente, Ana Eugenia
Interstitial 14q32 deletions involving IGH gene are infrequent events in chronic lymphocytic leukemia (CLL), affecting less than 5% of patients. To date, little is known about their clinical impact and molecular underpinnings, and its mutational landscape is currently unknown. In this work, a total of 871 CLLs were tested for the IGH break-apart probe, and 54 (6.2%) had a 300 kb deletion of 30 IGH (del-30 IGH CLLs), which contributed to a shorter time to first treatment (TFT). The mutational analysis by next-generation sequencing of 317 untreated CLLs (54 del-30 IGH and 263 as the control group) showed high mutational frequencies of NOTCH1 (30%), ATM (20%), genes involved in the RAS signaling pathway (BRAF, KRAS, NRAS, and MAP2K1) (15%), and TRAF3 (13%) within del-30 IGH CLLs. Notably, the incidence of TRAF3 mutations was significantly higher in del-30 IGH CLLs than in the control group (p < .001). Copy number analysis also revealed that TRAF3 loss was highly enriched in CLLs with 14q deletion (p < .001), indicating a complete biallelic inactivation of this gene through deletion and mutation. Interestingly, the presence of mutations in the aforementioned genes negatively refined the prognosis of del-30 IGH CLLs in terms of overall survival (NOTCH1, ATM, and RAS signaling pathway genes) and TFT (TRAF3). Furthermore, TRAF3 biallelic inactivation constituted an independent risk factor for TFT in the entire CLL cohort. Altogether, our work demonstrates the distinct genetic landscape of del-30 IGH CLL with multiple molecular pathways affected, characterized by a TRAF3 biallelic inactivation that contributes to a marked poor outcome in this subgroup of patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Species-specific modulation of food-search behavior by respiration and chemosensation in Drosophila larvae

  • Kim, Daeyeon
  • Alvarez, Mar|||0000-0003-4590-4401
  • Lechuga, Laura M.|||0000-0001-5187-5358
  • Louis, Matthieu|||0000-0002-2267-0262
Animals explore their environment to encounter suitable food resources. Despite its vital importance, this behavior puts individuals at risk by consuming limited internal energy during locomotion. We have developed a novel assay to investigate how food-search behavior is organized in Drosophila melanogaster larvae dwelling in hydrogels mimicking their natural habitat. We define three main behavioral modes: resting at the gel's surface, digging while feeding near the surface, and apneic dives. In unstimulated conditions, larvae spend most of their time digging. By contrast, deep and long exploratory dives are promoted by olfactory stimulations. Hypoxia and chemical repellents impair diving. We report remarkable differences in the dig-and-dive behavior of D. melanogaster and the fruit-pest D. suzukii. The present paradigm offers an opportunity to study how sensory and physiological cues are integrated to balance the limitations of dwelling in imperfect environmental conditions and the risks associated with searching for potentially more favorable conditions.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Novel homozygous OSGEP gene pathogenic variants in two unrelated patients with Galloway-Mowat syndrome, case report and review of the literature

  • Domingo, Andrea|||0000-0003-3759-7595
  • Furlano, Monica|||0000-0003-1025-3901
  • Pybus, Marc|||0000-0002-6195-5738
  • Barraca, Daniel
  • Martínez, Ana Belén
  • Mora Muñoz, Emiliano
  • Torra Balcells, Roser|||0000-0001-8714-2332
  • Ars, Elisabet|||0000-0002-4118-4358
Galloway-Mowat syndrome (GAMOS) is a rare autosomal recessive disorder characterized by early-onset nephrotic syndrome and microcephaly with brain anomalies. WDR73 pathogenic variants were described as the first genetic cause of GAMOS and, very recently, four novel causative genes, OSGEP, LAGE3, TP53RK, and TPRKB, have been identified. We present the clinical and genetic characteristics of two unrelated infants with clinical suspicion of GAMOS who were born from consanguineous parents. Both patients showed a similar clinical presentation, with early-onset nephrotic syndrome, microcephaly, brain atrophy, developmental delay, axial hypotonia, and early fatality. We identified two novel likely disease-causing variants in the OSGEP gene. These two cases, in conjunction with the findings of a literature review, indicate that OSGEP pathogenic variants are associated with an earlier onset of nephrotic syndrome and shorter life expectancy than WDR73 pathogenic variants. Our findings expand the spectrum of pathogenic variants in the OSGEP gene and, taken in conjunction with the results of the literature review, suggest that the OSGEP gene should be considered the main known monogenic cause of GAMOS. Early genetic diagnosis of GAMOS is of paramount importance for genetic counseling and family planning.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

MYH9-related disease, it does exist, may be more frequent than you think and requires specific therapy

  • Fernandez-Prado, Raul
  • Carriazo-Julio, Sol Maria
  • Torra Balcells, Roser|||0000-0001-8714-2332
  • Ortiz, Alberto|||0000-0002-9805-9523
  • Pérez-Gómez, Maria Vanessa|||0000-0003-4558-5236
In this issue of ckj, Tabibzadeh et al. report one of the largest series of patients with MYH9 mutations and kidney disease. The cardinal manifestation of MYH9-related disease is thrombocytopenia with giant platelets. The population frequency of pathogenic MYH9 mutations may be at least 1 in 20 000. The literature abounds in misdiagnosed cases treated for idiopathic thrombocytopenic purpura with immune suppressants and even splenectomy. Additional manifestations include neurosensorial deafness and proteinuric and hematuric progressive kidney disease (at some point, it was called Alport syndrome with macrothrombocytopenia), leucocyte inclusions, cataracts and liver enzyme abnormalities, resulting in different names for different manifestation combinations (MATINS, May-Hegglin anomaly, Fechtner, Epstein and Sebastian syndromes, and deafness AD 17). The penetrance and severity of kidney disease are very variable, which may obscure the autosomal dominant inheritance. A correct diagnosis will both preclude unnecessary and potentially dangerous therapeutic interventions and allow genetic counselling and adequate treatment. Morphological erythrocyte, granulocyte and platelet abnormalities may allow the future development of high-throughput screening techniques adapted to clinical peripheral blood flow cytometers.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

How genomics reclassifies diseases, the case of Alport syndrome

  • Torra Balcells, Roser|||0000-0001-8714-2332
  • Furlano, Monica|||0000-0003-1025-3901
  • Ars, Elisabet|||0000-0002-4118-4358
In this issue, Matthews et al. provide a comprehensive review of published cohorts with heterozygous pathogenic variants in COL4A3 or COL4A4, documenting the wide spectrum of the disease. Due to the extreme phenotypes that patients with heterozygous pathogenic variants in COL4A3 or COL4A4 may show, the disease has been referred to in a variety of ways, including 'autosomal dominant Alport syndrome', 'thin basement membrane disease', 'thin basement membrane nephropathy', 'familial benign hematuria' and 'carriers of autosomal dominant Alport syndrome'. This confusion over terminology has prevented nephrologists from being sufficiently aware of the relevance of the entity. Nowadays, however, next-generation sequencing facilitates the diagnosis and it is becoming a relatively frequent finding in haematuric-proteinuric nephropathies of unknown origin, even in non-familial cases. There is a need to raise awareness among nephrologists about the disease in order to improve diagnosis and provide better management for these patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A Computational Model of the Fetal Circulation to Quantify Blood Redistribution in Intrauterine Growth Restriction

  • Garcia-Canadilla, Patricia
  • Rudenick, Paula A.|||0000-0003-0561-0193
  • Crispi, Fatima|||0000-0002-7422-5240
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Palau, Georgina
  • Camara, Oscar|||0000-0002-5125-6132
  • Gratacós, Eduard|||0000-0002-7405-7224
  • Bijens, Bart H.
Intrauterine growth restriction (IUGR) due to placental insufficiency is associated with blood flow redistribution in order to maintain delivery of oxygenated blood to the brain. Given that, in the fetus the aortic isthmus (AoI) is a key arterial connection between the cerebral and placental circulations, quantifying AoI blood flow has been proposed to assess this brain sparing effect in clinical practice. While numerous clinical studies have studied this parameter, fundamental understanding of its determinant factors and its quantitative relation with other aspects of haemodynamic remodeling has been limited. Computational models of the cardiovascular circulation have been proposed for exactly this purpose since they allow both for studying the contributions from isolated parameters as well as estimating properties that cannot be directly assessed from clinical measurements. Therefore, a computational model of the fetal circulation was developed, including the key elements related to fetal blood redistribution and using measured cardiac outflow profiles to allow personalization. The model was first calibrated using patient-specific Doppler data from a healthy fetus. Next, in order to understand the contributions of the main parameters determining blood redistribution, AoI and middle cerebral artery (MCA) flow changes were studied by variation of cerebral and peripheral-placental resistances. Finally, to study how this affects an individual fetus, the model was fitted to three IUGR cases with different degrees of severity. In conclusion, the proposed computational model provides a good approximation to assess blood flow changes in the fetal circulation. The results support that while MCA flow is mainly determined by a fall in brain resistance, the AoI is influenced by a balance between increased peripheral-placental and decreased cerebral resistances. Personalizing the model allows for quantifying the balance between cerebral and peripheral-placental remodeling, thus providing potentially novel information to aid clinical follow up. Intrauterine growth restriction (IUGR) is one of the leading causes of perinatal mortality and can be defined as a low birth weight together with signs of chronic hypoxia or malnutrition. It is mostly due to placental insufficiency resulting in a chronic restriction of oxygen and nutrients to the fetus. IUGR leads to cardiac dysfunction in utero which can persist postnatally. Under these altered conditions, IUGR fetuses redistribute their blood in order to maintain delivery of oxygenated blood to the brain, known as brain sparing. Given that, in the fetus the aortic isthmus (AoI) is a key arterial connection between the cerebral and placental circulations, quantifying AoI blood flow has been proposed to assess this brain sparing effect in clinical practice. However, which remodeling or redistribution processes in the cardiovascular systems induce the observed changes in AoI flow in IUGR fetuses is not fully understood. We developed a computational model of the fetal circulation, including the key elements related to fetal blood redistribution. Using measured cardiac outflow profiles to allow personalization, we can recreate and better understand the blood flow changes in individual IUGR fetuses.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease

  • Górriz, Jose Luis|||0000-0002-1134-9051
  • Arroyo, David|||0000-0003-4652-0311
  • D'Marco, Luis|||0000-0003-0148-891X
  • Torra Balcells, Roser|||0000-0001-8714-2332
  • Tomás, Patricia
  • Puchades, María Jesús
  • Panizo, Nayara|||0000-0002-1329-2976
  • Pantoja, Jonay
  • Montomoli, Marco|||0000-0003-1412-6352
  • Llisterri, José Luis
  • Pallarés Carratalá, Vicente|||0000-0002-2985-6078
  • Valdivielso, José Manuel|||0000-0003-1343-0184
Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent hereditary renal disease. There is an increased rate of cardiovascular disease (CVD) in ADPKD. In this study, we evaluate the prevalence of cardiovascular risk factors, the achievement rates for treatment goals and cardiovascular events (CVE) in ADPKD and their relations with asymptomatic CVD in CKD from other etiologies (CKDoe) and controls. We evaluated 2445 CKD patients (2010-2012). The information collected was: clinical, anthropometric and analytical parameters, treatments and CVD evaluation (intima-media thickness (IMT), atheromatous plaque presence and ankle-brachial index (ABI)). Laboratory, vital status, CVE and hospitalizations were collected for 4 years. ADPKD patients had a worse renal function and worst achievement of blood pressure, higher parathormone levels but lower proteinuria compared to CKDoe. ADPKD patients presented lower IMT values than other groups, however, an intermediate rate of pathologic ABI and atheromatous plaque was present. More than half of the patients received statins, achieving LDL-c levels < 100 only in 50 and 39.8% of them (ADPKD and CKDoe respectively). The number of CVE during the follow-up period was low. In adjusted Cox regression model, ADPDK had the lowest occurrence of CVE of all three groups (HR:0.422, 95%CI 0.221-0.808, p = 0.009). ADPKD patients show intermediate control rates of CVD. A better control of CVD risk seems to be related with a lower load of CVD compared to other groups, which may lead in the long term to a better prognosis. Further investigation is necessary to determine cardiovascular prognosis in ADPKD. The online version contains supplementary material available at 10.1186/s12882-021-02313-1.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The 2019 and 2021 International Workshops on Alport Syndrome

  • Daga, Sergio
  • Ding, Jie
  • Savige, Judy|||0000-0002-6813-0288
  • Lipska-Ziętkiewicz, Beata S.|||0000-0002-4169-9685
  • Hoefele, Julia|||0000-0002-7917-7129
  • Flinter, Frances
  • Gale, Daniel|||0000-0002-9170-1579
  • Aksenova, Marina|||0000-0002-3699-1884
  • Kai, Hirofumi
  • Perin, Laura
  • Barua, Moumita
  • Torra Balcells, Roser|||0000-0001-8714-2332
  • Miner, Jeff H.|||0000-0002-1510-8714
  • Massella, Laura|||0000-0001-5796-3965
  • Ljubanović, Danica Galešić
  • Lennon, Rachel|||0000-0001-6400-0227
  • Weinstock, Andrè B.
  • Knebelmann, Bertrand
  • Cerkauskaite, Agne
  • Gear, Susie
  • Gross, Oliver|||0000-0002-8390-8852
  • Turner, A. Neil|||0000-0003-4547-873X
  • Baldassarri, Margherita
  • Pinto, Anna Maria|||0000-0001-6259-6901
  • Renieri, Alessandra|||0000-0002-0846-9220
In 1927 Arthur Cecil Alport, a South African physician, described a British family with an inherited form of kidney disease that affected males more severely than females and was sometimes associated with hearing loss. In 1961, the eponymous name Alport syndrome was adopted. In the late twentieth century three genes responsible for the disease were discovered: COL4A3, COL4A4, and COL4A5 encoding for the α3, α4, α5 polypeptide chains of type IV collagen, respectively. These chains assemble to form heterotrimers of type IV collagen in the glomerular basement membrane. Scientists, clinicians, patient representatives and their families, and pharma companies attended the 2019 International Workshop on Alport Syndrome, held in Siena, Italy, from October 22 to 26, and the 2021 online Workshop from November 30 to December 4. The main topics included: disease re-naming, acknowledging the need to identify an appropriate term able to reflect considerable clinical variability; a strategy for increasing the molecular diagnostic rate; genotype-phenotype correlation from monogenic to digenic forms; new therapeutics and new therapeutic approaches; and gene therapy using gene editing. The exceptional collaborative climate that was established in the magical medieval setting of Siena continued in the online workshop of 2021. Conditions were established for collaborations between leading experts in the sector, including patients and drug companies, with the aim of identifying a cure for Alport syndrome.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Comparative analysis of tools to predict rapid progression in autosomal dominant polycystic kidney disease

  • Naranjo, Javier|||0000-0002-7004-6122
  • Furlano, Monica|||0000-0003-1025-3901
  • Torres, Ferran|||0000-0002-7355-7913
  • Hernández Mancera, Jonathan|||0000-0002-2267-7536
  • Pybus, Marc|||0000-0002-6195-5738
  • Ejarque, Laia
  • Cordoba, Christian|||0000-0003-4534-2760
  • Guirado, Luis|||0000-0001-5119-3912
  • Ars, Elisabet|||0000-0002-4118-4358
  • Torra Balcells, Roser|||0000-0001-8714-2332
Background: Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic kidney disease and shows a wide phenotype. Only patients with rapid progression (RP) are included in clinical trials or are approved to receive disease-modifying drugs. This study aims at comparing different available predictive tools in ADPKD with the Mayo classification (MC) identification of rapid progressors based on high total kidney volume (TKV) according to age. Methods: A total of 164 ADPKD patients were recruited retrospectively from a single centre. The performance of diverse tools to identify RP defined as being in MC categories 1C-1E was assessed. Results: A total of 118 patients were MC 1C-1E. The algorithm developed by the European Renal Association-European Dialysis and Transplant Association Working Group on Inherited Kidney Disorders/European Renal Best Practice had a low sensitivity in identifying MC 1C-1E. The sensitivity and specificity of TKV to predict RP depend on the cut-off used. A kidney length of.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Clinical and Genetic Features of Autosomal Dominant Alport Syndrome, A Cohort Study

  • Furlano, Monica|||0000-0003-1025-3901
  • Martínez, Victor
  • Pybus, Marc|||0000-0002-6195-5738
  • Arce, Yolanda
  • Crespí, Jaume|||0000-0001-7564-2479
  • Venegas, María del Prado|||0000-0001-9048-4501
  • Bullich Vilanova, Gemma|||0000-0002-0737-4422
  • Domingo, Andrea|||0000-0003-3759-7595
  • Ayasreh Fierro, Nadia|||0000-0001-6436-5621
  • Benito, Silvia
  • Lorente, Laura
  • Ruíz, Patricia
  • Gonzalez, Vanesa L.
  • Arlandis, Rosa
  • Cabello, Elisa
  • Torres, Ferran|||0000-0002-7355-7913
  • Guirado, Luis|||0000-0001-5119-3912
  • Ars, Elisabet|||0000-0002-4118-4358
  • Torra Balcells, Roser|||0000-0001-8714-2332
Rationale & Objective: Alport syndrome is a common genetic kidney disease accounting for approximately 2% of patients receiving kidney replacement therapy (KRT). It is caused by pathogenic variants in the gene COL4A3, COL4A4, or COL4A5. The aim of this study was to evaluate the clinical and genetic spectrum of patients with autosomal dominant Alport syndrome (ADAS). Study Design: Retrospective cohort study. Setting & Participants: 82 families (252 patients) with ADAS were studied. Clinical, genetic, laboratory, and pathology data were collected. Observations: A pathogenic DNA variant in COL4A3 was identified in 107 patients (35 families), whereas 133 harbored a pathogenic variant in COL4A4 (43 families). Digenic/complex inheritance was observed in 12 patients. Overall, the median kidney survival was 67 (95% CI, 58-73) years, without significant differences across sex (P = 0.8), causative genes (P = 0.6), or type of variant (P = 0.9). Microhematuria was the most common kidney manifestation (92.1%), and extrarenal features were rare. Findings on kidney biopsies ranged from normal to focal segmental glomerulosclerosis. The slope of estimated glomerular filtration rate change was -1.46 (-1.66 to -1.26) mL/min/1.73 m per year for the overall group, with no significant differences between ADAS genes (P = 0.2). Limitations: The relatively small size of this series from a single country, potentially limiting generalizability. Conclusions: Patients with ADAS have a wide spectrum of clinical presentations, ranging from asymptomatic to kidney failure, a pattern not clearly related to the causative gene or type of variant. The diversity of ADAS phenotypes contributes to its underdiagnosis in clinical practice.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Genetic kidney diseases as an underrecognized cause of chronic kidney disease, the key role of international registry reports

  • Torra Balcells, Roser|||0000-0001-8714-2332
  • Furlano, Monica|||0000-0003-1025-3901
  • Ortiz, Alberto|||0000-0002-9805-9523
  • Ars, Elisabet|||0000-0002-4118-4358
Inherited kidney diseases (IKDs) are among the leading causes of early-onset chronic kidney disease (CKD) and are responsible for at least 10-15% of cases of kidney replacement therapy (KRT) in adults. Paediatric nephrologists are very aware of the high prevalence of IKDs among their patients, but this is not the case for adult nephrologists. Recent publications have demonstrated that monogenic diseases account for a significant percentage of adult cases of CKD. A substantial number of these patients have received a non-specific/incorrect diagnosis or a diagnosis of CKD of unknown aetiology, which precludes correct treatment, follow-up and genetic counselling. There are a number of reasons why genetic kidney diseases are difficult to diagnose in adulthood: (i) adult nephrologists, in general, are not knowledgeable about IKDs; (ii) existence of atypical phenotypes; (iii) genetic testing is not universally available; (iv) family history is not always available or may be negative; (v) lack of knowledge of various genotype-phenotype relationships and (vi) conflicting interpretation of the pathogenicity of many sequence variants. Registries can contribute to visualize the burden of IKDs by regularly grouping all IKDs in their annual reports, as is done for glomerulonephritis or interstitial diseases, rather than reporting only cystic disease and hiding other IKDs under labels such as 'miscellaneous' or 'other'. Any effort to reduce the percentage of patients needing KRT with a diagnosis of 'nephropathy of unknown etiology' or an unspecific/incorrect diagnosis should be encouraged as a step towards precision nephrology. Genetic testing may be of value in this context but should not be used indiscriminately, but rather on the basis of a deep knowledge of IKDs.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Proposal of the colour pattern reconstruction of basal cervids

  • Gamarra González, Jesús|||0000-0002-9474-2317
  • Vega-Pagán, Kelly Ann|||0000-0001-8966-5348
  • Rodríguez Alba, Juan José|||0000-0001-7253-0199
  • Pérez González, Sergio
  • Fesharaki, Omid|||0000-0003-1594-2466
Methodologies that analyse the colouration and external appearance of extant species are very useful tools when facing one of the greatest challenges in the palaeoartistic reconstructions of extinct fauna: inferring the colour patterns. Earlier works have applied this methodology, for example, in the reconstruction of the Miocene bovid Tethytragus, proving that the maximum likelihood (ML) analysis to infer ancestral states has promising potential. This study offers a proposal for the reconstruction of the external appearance of Heteroprox moralesi Azanza 1989, an early cervid of the Middle Miocene present in several fossil sites of Central Spain. For the reconstruction of the external appearance, the colour patterns of all the extant species of the family Cervidae were studied with the method of ML analysis, as well as recent works about their phylogeny. The results show the most probable basal colour pattern of the cervids: dark shades on the limbs, dorsal section, and head of the animal, and, in contrast, lighter colours on the neck and perianal region. This basal pattern can be used as a basis for reconstructing colouration and to hypothesise about the external appearance of extinct taxa. Furthermore, the inferred forest habitat of H. moralesi has been taken into consideration in order to adjust the colour pattern, comparing the final results of the analysis performed in this study with that of the pattern observed in extant forest deer as well as with previous works employing this methodology.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The Benefits of Early versus Late Therapeutic Intervention in Fabry Disease

  • Furlano, Monica|||0000-0003-1025-3901
  • Ars, Elisabet|||0000-0002-4118-4358
  • Matamala Gastón, Ana María
  • Brossa Loidi, Vicens|||0000-0003-0403-6425
  • Martí-Fàbregas, Joan|||0000-0001-9229-8649
  • Venegas, María del Prado|||0000-0001-9048-4501
  • Crespí, Jaume|||0000-0001-7564-2479
  • Roé Crespo, Esther|||0000-0003-1601-9227
  • Torra Balcells, Roser|||0000-0001-8714-2332
Fabry disease (FD) is an X-linked lysosomal storage disorder caused by pathogenic variants of the GLA gene. Heterozygous female patients may show much more variability in clinical manifestations, ranging from asymptomatic to full-blown disease. Because of this heterogeneous clinical picture in women, the diagnosis of FD has typically been delayed for more than a decade, and the optimal time to initiate treatment remains controversial. Case Presentation. Here, we present two unrelated female patients diagnosed with FD harbouring the same pathogenic GLA variant. We discuss the implications of initiating specific therapy at different stages of the disease, with and without organ involvement (early versus late therapeutic intervention). These clinical cases suggest that initiating specific treatment at an earlier age in women with FD may prevent organ involvement and associated clinical events.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Autosomal dominant polycystic kidney disease in young adults

  • Martínez, Víctor
  • Furlano, Monica|||0000-0003-1025-3901
  • Sans, Laia
  • Pulido, Lissett
  • García, Rebeca|||0000-0003-0649-2766
  • Pérez-Gómez, Maria Vanessa|||0000-0003-4558-5236
  • Sánchez-Rodríguez, Jinny
  • Blasco Pelicano, Miquel|||0000-0003-0789-7992
  • Castro-Alonso, Cristina|||0000-0002-8363-1953
  • Fernández-Fresnedo, Gema
  • Robles, Nicolás Roberto|||0000-0003-4984-6691
  • Valenzuela, María Pau
  • Naranjo, Javier|||0000-0002-7004-6122
  • Martín Alemany, Nàdia|||0000-0002-4370-7562
  • Pilco-Teran, Melissa|||0000-0002-1311-0896
  • Agraz Pamplona, Irene|||0000-0002-4223-6834
  • González-Rodríguez, Juan David|||0000-0002-8863-2007
  • Panizo, Nayara|||0000-0002-1329-2976
  • Fraga Rodriguez, Gloria Maria|||0000-0002-7682-1396
  • Fernández, Loreto
  • López, María Teresa
  • Dall'Anese, Cecilia
  • Ortiz, Alberto|||0000-0002-9805-9523
  • Torra Balcells, Roser|||0000-0001-8714-2332
The clinical manifestations of autosomal dominant polycystic kidney disease (ADPKD) usually appear in adulthood, however pediatric series report a high morbidity. The objective of the study was to analyze the clinical characteristics of ADPKD in young adults. Family history, hypertension, albuminuria, estimated glomerular filtration rate (eGFR) and imaging tests were examined in 346 young adults (18-30 years old) out of 2521 patients in the Spanish ADPKD registry (REPQRAD). A literature review searched for reports on hypertension in series with more than 50 young (age <30 years) ADPKD patients. The mean age of this young adult cohort was 25.24 (SD 3.72) years. The mean age at diagnosis of hypertension was 21.15 (SD 4.62) years, while in the overall REPQRAD population was aged 37.6 years. The prevalence of hypertension was 28.03% and increased with age (18-24 years, 16.8%; 25-30 years, 36.8%). Although prevalence was lower in women than in men, the age at onset of hypertension (21 years) was similar in both sexes. Mean eGFR was 108 (SD 21) mL/min/1.73 m 2, 38.0% had liver cysts and 3.45% of those studied had intracranial aneurysms. In multivariate analyses, hematuria episodes and kidney length were independent predictors of hypertension (area under the curve 0.75). The prevalence of hypertension in 22 pediatric cohorts was 20%-40%, but no literature reports on hypertension in young ADPKD adults were found. Young adults present non-negligible ADPKD-related morbidity. This supports the need for a thorough assessment of young adults at risk of ADPKD that allows early diagnosis and treatment of hypertension.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Recomendaciones de manejo de la afectación renal en el complejo esclerosis tuberosa

  • Ariceta Iraola, Gema|||0000-0003-1763-1098
  • Buj Pradilla, María José
  • Furlano, Monica|||0000-0003-1025-3901
  • Martínez, V.
  • Matamala, Anna|||0000-0002-1607-9011
  • Morales, M.
  • Robles, N.R.
  • Sans, Laia
  • Villacampa, F.
  • Torra Balcells, Roser|||0000-0001-8714-2332
El complejo esclerosis tuberosa (CET) es una enfermedad rara, hereditaria, multisistémica y con un amplio espectro fenotípico. Su manejo requiere de la colaboración de múltiples especialistas. Así como en la edad pediátrica cobra un especial relieve el neurólogo pediatra, en la edad adulta la afectación renal es la causante de la mayor morbimortalidad. Existen diversas recomendaciones sobre el manejo general del paciente con CET, pero ninguna que se centre en la afectación renal. Las presentes recomendaciones responden a la necesidad de proporcionar pautas para facilitar un mejor conocimiento y manejo diagnóstico-terapéutico de la afectación renal del CET mediante un uso racional de las pruebas complementarias y el empleo correcto de los tratamientos disponibles. Su elaboración se ha basado en el consenso dentro del grupo de trabajo de enfermedades renales hereditarias de la SEN/REDINREN. Ha contado con la participación de especialistas en CET no nefrólogos también con el fin de ampliar la visión de la enfermedad.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1

  • Olinger, Eric|||0000-0003-1178-7980
  • Hofmann, Patrick|||0000-0002-4586-641X
  • Kidd, Kendrah|||0000-0003-3771-0949
  • Dufour, Inès
  • Belge, Hendrica
  • Schaeffer, Céline|||0000-0001-5883-3951
  • Kipp, Anne
  • Bonny, Olivier
  • Deltas, Constantinos|||0000-0001-5549-9169
  • Demoulin, Nathalie|||0000-0002-3566-3950
  • Fehr, Thomas|||0000-0003-1668-1800
  • Fuster, D.G.|||0000-0001-7220-1803
  • Gale, Daniel|||0000-0002-9170-1579
  • Goffin, Eric|||0000-0001-9242-7148
  • Hodaňová, Kateřina|||0000-0001-9172-9945
  • Huynh-Do, Uyen|||0000-0002-7276-032X
  • Kistler, Andreas|||0000-0002-4114-9560
  • Morelle, Johann|||0000-0002-6925-1989
  • Papagregoriou, Gregory|||0000-0002-2440-9789
  • Pirson, Yves
  • Sandford, Richard
  • Sayer, John|||0000-0003-1881-3782
  • Torra Balcells, Roser|||0000-0001-8714-2332
  • Venzin, Christina
  • Venzin, Reto
  • Vogt, Bruno|||0000-0002-1548-6387
  • Živná, Martina
  • Greka, Anna|||0000-0001-5697-7791
  • Dahan, Karin
  • Rampoldi, Luca|||0000-0002-0544-7042
  • Kmoch, Stanislav
  • Bleyer, Anthony|||0000-0002-2804-5273
  • Devuyst, Olivier|||0000-0003-3744-4767
Autosomal dominant tubulointerstitial kidney disease (ADTKD) is an increasingly recognized cause of end-stage kidney disease, primarily due to mutations in UMOD and MUC1. The lack of clinical recognition and the small size of cohorts have slowed the understanding of disease ontology and development of diagnostic algorithms. We analyzed two registries from Europe and the United States to define genetic and clinical characteristics of ADTKD-UMOD and ADTKD-MUC1 and develop a practical score to guide genetic testing. Our study encompassed 726 patients from 585 families with a presumptive diagnosis of ADTKD along with clinical, biochemical, genetic and radiologic data. Collectively, 106 different UMOD mutations were detected in 216/562 (38.4%) of families with ADTKD (303 patients), and 4 different MUC1 mutations in 72/205 (35.1%) of the families that are UMOD-negative (83 patients). The median kidney survival was significantly shorter in patients with ADTKD-MUC1 compared to ADTKD-UMOD (46 vs. 54 years, respectively), whereas the median gout-free survival was dramatically reduced in patients with ADTKD-UMOD compared to ADTKD-MUC1 (30 vs. 67 years, respectively). In contrast to patients with ADTKD-UMOD, patients with ADTKD-MUC1 had normal urinary excretion of uromodulin and distribution of uromodulin in tubular cells. A diagnostic algorithm based on a simple score coupled with urinary uromodulin measurements separated patients with ADTKD-UMOD from those with ADTKD-MUC1 with a sensitivity of 94.1%, a specificity of 74.3% and a positive predictive value of 84.2% for a UMOD mutation. Thus, ADTKD-UMOD is more frequently diagnosed than ADTKD-MUC1, ADTKD subtypes present with distinct clinical features, and a simple score coupled with urine uromodulin measurements may help prioritizing genetic testing.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Small Non-Coding RNAs and Their Role in Locoregional Metastasis and Outcomes in Early-Stage Breast Cancer Patients

  • Escuin i Borràs, Daniel|||0000-0003-3538-0579
  • Bell, Olga|||0009-0000-2858-6187
  • García-Valdecasas Vilanova, Bárbara|||0000-0002-2728-5208
  • Clos Enríquez, Montserrat|||0000-0001-7548-612X
  • Larrañaga, Itziar|||0000-0003-2708-4913
  • López Vilaró, Laura|||0000-0002-5428-8017
  • Mora Brugués, Josefina|||0000-0001-6777-5132
  • Andrés Nieto, Marta|||0000-0001-5267-0039
  • Arqueros, Cristina|||0000-0003-1249-2324
  • Barnadas i Molins, Agustí|||0000-0002-0429-1349
Deregulation of small non-coding RNAs (sncRNAs) has been associated with the onset of metastasis. We evaluated the expression of sncRNAs in patients with early-stage breast cancer, performing RNA sequencing in 60 patients for whom tumor and sentinel lymph node (SLN) samples were available, and conducting differential expression, gene ontology, enrichment and survival analyses. Sequencing annotation classified most of the sncRNAs into small nucleolar RNA (snoRNAs, 70%) and small nuclear RNA (snRNA, 13%). Our results showed no significant differences in sncRNA expression between tumor or SLNs obtained from the same patient. Differential expression analysis showed down-regulation (n = 21) sncRNAs and up-regulation (n = 2) sncRNAs in patients with locoregional metastasis. The expression of SNHG5, SNORD90, SCARNA2 and SNORD78 differentiated luminal A from luminal B tumors, whereas SNORD124 up-regulation was associated with luminal B HER2+ tumors. Discriminating analysis and receiver-operating curve analysis revealed a signature of six snoRNAs (SNORD93, SNORA16A, SNORD113-6, SNORA7A, SNORA57 and SNORA18A) that distinguished patients with locoregional metastasis and predicted patient outcome. Gene ontology and Reactome pathway analysis showed an enrichment of biological processes associated with translation initiation, protein targeting to specific cell locations, and positive regulation of Wnt and NOTCH signaling pathways, commonly involved in the promotion of metastases. Our results point to the potential of several sncRNAs as surrogate markers of lymph node metastases and patient outcome in early-stage breast cancer patients. Further preclinical and clinical studies are required to understand the biological significance of the most significant sncRNAs and to validate our results in a larger cohort of patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Correction, The 2019 and 2021 International workshops on Alport syndrome

  • Daga, Sergio
  • Ding, Jie
  • Deltas, Constantinos|||0000-0001-5549-9169
  • Savige, Judy|||0000-0002-6813-0288
  • Lipska-Ziętkiewicz, Beata S.|||0000-0002-4169-9685
  • Hoefele, Julia|||0000-0002-7917-7129
  • Flinter, Frances
  • Gale, Daniel|||0000-0002-9170-1579
  • Aksenova, Marina|||0000-0002-3699-1884
  • Kai, Hirofumi
  • Perin, Laura
  • Barua, Moumita
  • Torra Balcells, Roser|||0000-0001-8714-2332
  • Miner, Jeff H.|||0000-0002-1510-8714
  • Massella, Laura|||0000-0001-5796-3965
  • Ljubanović, Danica Galešić
  • Lennon, Rachel|||0000-0001-6400-0227
  • Weinstock, Andrè B.
  • Knebelmann, Bertrand
  • Cerkauskaite, Agne
  • Gear, Susie
  • Gross, Oliver|||0000-0002-8390-8852
  • Turner, A. Neil|||0000-0003-4547-873X
  • Baldassarri, Margherita
  • Pinto, Anna Maria|||0000-0001-6259-6901
  • Renieri, Alessandra|||0000-0002-0846-9220
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Circulating miRNA Expression Is Inversely Correlated with Tumor Tissue or Sentinel Lymph Nodes in Estrogen Receptor-Positive Early Breast Cancer Patients

  • Escuin i Borràs, Daniel|||0000-0003-3538-0579
  • López Vilaró, Laura|||0000-0002-5428-8017
  • Bell, Olga|||0009-0000-2858-6187
  • Mora Brugués, Josefina|||0000-0001-6777-5132
  • García-Valdecasas Vilanova, Bárbara|||0000-0002-2728-5208
  • Moral, Antonio|||0000-0001-5551-0145
  • Clos Enríquez, Montserrat|||0000-0001-7548-612X
  • Boronat, Laia
  • Arqueros, Cristina|||0000-0003-1249-2324
  • Barnadas i Molins, Agustí|||0000-0002-0429-1349
The deregulation of microRNAs (miRNAs) is associated with the various steps of the metastatic process. In addition, circulating miRNAs are remarkably stable in peripheral blood, making them ideal noninvasive biomarkers for disease diagnosis. Here, we performed a proof-of-principle study to determine whether tumor-tissue-derived miRNAs are traceable to plasma in ER-positive early breast cancer patients. We performed RNA-sequencing on 30 patients for whom plasma, sentinel lymph nodes (SLNs) and tumor tissue were available. We carried out differential expression, gene ontology and enrichment analyses. Our results show that circulating miRNAs are inversely expressed compared with tumor tissue or SLNs obtained from the same patients. Our differential expression analysis shows the overall downregulation of circulating miRNAs. However, the expression of miR-643a-3p and miR-223 was up-regulated in patients with positive SLNs. Furthermore, gene ontology analysis showed the significant enrichment of biological processes associated with the regulation of epithelial cell proliferation and transcriptional regulation commonly involved in the promotion of metastases. Our results suggest the potential role of several circulating miRNAs as surrogate markers of lymph node metastases in early breast cancer patients. Further preclinical and clinical studies are required to understand the biological significance of the most significant miRNAs and to validate our results in a larger cohort of patients.